We are live on ! Find out more
BF

BOK Financial Portfolio holdings

AUM $6.54B
1-Year Est. Return 25.41%
This Fund
S&P 500
This Quarter Est. Return
+9.85%
1 Year Est. Return
+25.41%
3 Year Est. Return
+74.09%
5 Year Est. Return
10 Year Est. Return
AUM
$6.46B
AUM Growth
+$647M
Cap. Flow
+$147M
Cap. Flow %
2.27%
Top 10 Hldgs %
22.61%
Holding
1,021
New
74
Increased
503
Reduced
335
Closed
46

Top Sells

Rank Stock Value
1
ABT icon
Abbott
ABT
+$35.9M
2
ABBV icon
AbbVie
ABBV
+$31M
3
PNW icon
Pinnacle West Capital
PNW
+$9.26M
4
MMM icon
3M
MMM
+$8.62M
5
HRC
HILL-ROM HOLDINGS, INC.
HRC
+$6.15M

Sector Composition

Rank Sector Weight
1 Technology 17.36%
2 Healthcare 10.12%
3 Financials 8.06%
4 Consumer Discretionary 7.26%
5 Industrials 6.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAT icon
151
Caterpillar
CAT
$375B
$9.66M 0.15%
46,735
-350
-0.7% -$70.5K
AEP icon
152
American Electric Power
AEP
$69.6B
$9.65M 0.15%
108,509
-16,438
-13% -$1.39M
YUM icon
153
Yum! Brands
YUM
$41.8B
$9.55M 0.15%
68,761
+320
+0.5% +$40.9K
VOE icon
154
Vanguard Morningstar Mid-Cap Value ETF
VOE
$23.7B
$9.44M 0.15%
62,817
+6,899
+12% +$1.01M
AZN icon
155
AstraZeneca
AZN
$263B
$9.24M 0.14%
79,330
+1,653
+2% +$195K
CME icon
156
CME Group
CME
$96.3B
$9.2M 0.14%
40,262
+1,632
+4% +$359K
PXD
157
DELISTED
Pioneer Natural Resource Co.
PXD
$9.09M 0.14%
49,972
+6,166
+14% +$1.13M
TROW icon
158
T. Rowe Price
TROW
$23.9B
$8.96M 0.14%
45,557
-1,599
-3% -$325K
GILD icon
159
Gilead Sciences
GILD
$162B
$8.91M 0.14%
122,787
+50,642
+70% +$3.49M
CTAS icon
160
Cintas
CTAS
$81.9B
$8.87M 0.14%
80,020
-2,716
-3% -$293K
DG icon
161
Dollar General
DG
$28B
$8.81M 0.14%
37,338
+1,772
+5% +$391K
IDXX icon
162
Idexx Laboratories
IDXX
$44.1B
$8.8M 0.14%
13,367
+978
+8% +$614K
LAMR icon
163
Lamar Advertising Co
LAMR
$16.2B
$8.79M 0.14%
72,501
+1,672
+2% +$195K
AMD icon
164
Advanced Micro Devices
AMD
$776B
$8.73M 0.14%
60,658
-5,050
-8% -$679K
VB icon
165
Vanguard Morningstar Small-Cap ETF
VB
$79.5B
$8.68M 0.13%
38,410
+1,160
+3% +$264K
EW icon
166
Edwards Lifesciences
EW
$49.6B
$8.64M 0.13%
66,726
+8,043
+14% +$938K
DGX icon
167
Quest Diagnostics
DGX
$25.7B
$8.61M 0.13%
49,743
+4,122
+9% +$627K
MCHP icon
168
Microchip Technology
MCHP
$40.3B
$8.48M 0.13%
97,361
+7,457
+8% +$603K
QRVO icon
169
Qorvo
QRVO
$7.99B
$8.4M 0.13%
53,690
-2,190
-4% -$348K
XLNX
170
DELISTED
Xilinx Inc
XLNX
$8.38M 0.13%
39,535
-1,347
-3% -$266K
VCIT icon
171
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.2B
$8.35M 0.13%
90,058
-9,988
-10% -$935K
BDX icon
172
Becton Dickinson
BDX
$45.6B
$8.32M 0.13%
33,909
-548
-2% -$131K
GD icon
173
General Dynamics
GD
$104B
$8.27M 0.13%
39,651
+97
+0.2% +$19.6K
TFC icon
174
Truist Financial
TFC
$63.3B
$8.19M 0.13%
139,818
+8,707
+7% +$532K
IBM icon
175
IBM
IBM
$211B
$8.13M 0.13%
60,818
-21,333
-26% -$2.68M

Similar funds

BOK Financial's Q4 2021 Portfolio in Review

As of Q4 2021, BOK Financial held 1,021 positions worth $6.46B, up 11% from $5.82B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

BOK Financial's Q4 2021 filing shows 74 new, 503 increased, 335 reduced and 46 closed positions. Its largest new stake was NexPoint Residential Trust: 152,754 shares worth $12.8M. The largest sale was Abbott, an estimated $35.9M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

  • BOK Financial's largest Q4 2021 buy was NexPoint Residential Trust: 152,754 shares worth $12.8M.
  • BOK Financial added most to Vanguard FTSE Emerging Markets ETF in Q4 2021, an estimated $33.3M increase.
  • BOK Financial's biggest Q4 2021 reduction was Abbott, cutting an estimated $35.9M.
  • BOK Financial fully exited Pinnacle West Capital in Q4 2021, selling an estimated $9.26M.
  • BOK Financial's ten largest holdings make up 23% of its $6.46B portfolio in Q4 2021.
  • BOK Financial opened 74 new positions and closed 46 in Q4 2021.
  • BOK Financial's portfolio value rose 11% quarter-over-quarter to $6.46B.

Based on BOK Financial's 13F filing for Q4 2021, filed 11 Mar 2022.